HRMY Harmony Biosciences Inc Total Business Assets
The market price visualization of Harmony Biosciences (HRMY) total assets, valued at 1240.73, demonstrates the strength of the pharmaceutical segment within the field of rare neurological pathologies. Harmony Biosciences (HRMY) relies on its exclusive ownership of Wakix therapy and a patient loyalty system. High brand authority ensures physician confidence in its wakefulness restoration methods. Strict patent control and its status as a unique treatment allow the company to exercise pricing power over insurance funds.
Analytical breakdowns and data insights for company Harmony Pharma (HRMY)
- stock value and consensus price forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Harmony Biosciences|HRMY - Long-Term Debt to Equity|Current Liabilities to Capital Harmony Corp|HRMY - Company Aggregate Debts|Debt to Net Assets Ratio Harmony Corp|HRMY - Company Long-Term Debts|Company Short-Term Debts Harmony Biosciences|Intermediate Coverage Ratio harmonybiosciences.com
- company profitability and valuation multiples indicators:
Fundamental valuation:harmonybiosciences.com (HRMY)
The development of Harmony Biosciences (HRMY) depends directly on the commercial success of Wakix and the expansion of its therapeutic indications through the FDA. By analyzing the organization's asset volume, an investor sees a set of resources calculated reversely via ROA, which allows for an assessment of the company's total capitalization and debt load to determine its financial resilience to market shocks.
Direct competitors
Company Assets biogen.com (BIIB)|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Biohaven Corp (BHVN)|AMLX (Amylyx Pharmaceuticals) - Company Total Assets|TRVI: Aggregate Asset Value|Company Total Assets PRAX|Company Total Assets Anavex (AVXL)|Aggregate Company Assets CeriBell Corp CBLL|Aggregate Asset Value PRTA|ALEC - Aggregate Company Assets|annexonbio.com (ANNX) - Cumulative Company Assets|omeros.com (OMER) - Aggregate Company Assets|Company Assets Neurogene Inc (NGNE)|Aggregate Company Assets AC Immune Corp|Total Business Assets VYGR (Voyager Corp)|Cumulative Company Assets NMRA (Neumora Therapeutics)|SCLX - Company Assets|Tevogen Bio - Cumulative Company Assets|Aggregate Asset Value ACOG|Cognition Therapeutics, Inc. - Company Total Assets|IKT: Aggregate Company Assets|SAVA: Company Total Assets|ASRT - Company Total Asset Base|Aggregate Company Assets Coya Therapeutics Inc|Company Assets VistaGen Therapeutics Inc VTGN|Aggregate Company Assets Ovid Therapeutics Inc. (OVID)|Company Total Asset Base Acumen Pharmaceuticals, Inc|Company Total Assets CRVO (CervoMed Inc.)|ATHE - Cumulative Company Assets|Clene Nanomedicine - Company Total Assets|Company Total Asset Base PepGen Inc. PEPG|JUNS: Company Total Assets|Company Assets Relmada Corp (RLMD)|Aggregate Company Assets Annovis Bio, Inc.|Total Business Assets GRCE (Grace Tx)|Company Total Assets AIFF|Cumulative Company Assets anewmeds.com KLTO|Company Total Assets NRSN (NeuroSense Therapeutics Ltd.)|Reviva Pharmaceuticals, Inc. (RVPH) - Company Assets|MTVA - Aggregate Company Assets|Company Total Asset Base neuraxis.com NRXS|HSDT: Company Total Assets|Passage Bio - Aggregate Asset Value|Aggregate Company Assets Neuphoria Therapeutics, Inc.|NERV: Aggregate Asset Value|Aggregate Company Assets Athira Pharma, Inc. (ATHA)|Cumulative Company Assets addextherapeutics.com ADXN|Alzamend Neuro - Cumulative Company Assets|Cyclerion Therapeutics Inc. (CYCN) - Company Assets|PTIX - Aggregate Company Assets|KTTA (Pasithea Therapeutics) - Total Business Assets|CRGT: Company Total Assets|Company Assets avenuetx.com (ATXI)|Cumulative Company Assets BCLI|Company Total Assets Cara Therapeutics Inc.|Aggregate Company Assets Chromocell Therapeutics Corporation (CHRO)|ELYM (eliemtx.com) - Aggregate Asset Value|Aggregate Company Assets Intra-Cellular Therapies, Inc. ITCI|longboardpharma.com (LBPH) - Company Assets|Marinus Pharmaceuticals, Inc. - Company Total Assets|Aggregate Asset Value NKGN (NKGen Biotech Inc)|NRBO: Company Total Assets|Sage Therapeutics Inc (SAGE) - Company Total Assets|Aggregate Company Assets Synaptogenix, Inc.|TRVN: Aggregate Asset Value|Aggregate Company Assets Vigil Neuroscience (VIGL)|Cumulative Company Assets anewmeds.com WENA|Aggregate Company Assets Cerevel CERE